We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+28.39%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.06B
AUM Growth
+$953M
Cap. Flow
+$556M
Cap. Flow %
10.99%
Top 10 Hldgs %
34.58%
Holding
150
New
52
Increased
21
Reduced
21
Closed
24

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$116M
2
ONCR
Oncorus, Inc.
ONCR
+$66M
3
TOI icon
The Oncology Institute
TOI
+$56.2M
4
CYTK icon
Cytokinetics
CYTK
+$45M
5
VTRS icon
Viatris
VTRS
+$40M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$196M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$142M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$96M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$74.4M
5
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
+$58.3M

Sector Composition

Rank Sector Weight
1 Healthcare 69.84%
2 Industrials 0.55%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIM
126
DELISTED
Alimera Sciences
ALIM
– –
-68,413
Closed -$332K
TCRR
127
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-1,200,000
Closed -$24.4M
ATNX
128
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-57,500
Closed -$13.9M
GNMK
129
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-175,806
Closed -$2.5M
LGVW.U
130
DELISTED
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
– –
-2,200,000
Closed -$22.3M
MYOK
131
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-704,000
Closed -$96M
ARYBU
132
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
– –
-500,000
Closed -$5.5M
IMMU
133
DELISTED
Immunomedics Inc
IMMU
– –
-2,304,900
Closed -$196M
MNK
134
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-1,970,687
Closed -$1.92M
HZNP
135
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-1,832,767
Closed -$142M
2 3 4 5
6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2020 Portfolio in Review

As of Q4 2020, Deerfield Management held 150 positions worth $5.06B, up 23% from $4.11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Deerfield Management deployed $556M of net new capital in Q4 2020, opening 52 new positions and adding to 21 existing holdings. Its largest new stake was Biogen: 448,000 shares worth $110M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 62% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was DFP Healthcare Acquisitions Corp. Unit, an estimated $58.3M trimmed.

  • Deerfield Management's largest Q4 2020 buy was Biogen: 448,000 shares worth $110M.
  • Deerfield Management added most to Viatris in Q4 2020, an estimated $40M increase.
  • Deerfield Management's biggest Q4 2020 reduction was DFP Healthcare Acquisitions Corp. Unit, cutting an estimated $58.3M.
  • Deerfield Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $196M.
  • Deerfield Management's ten largest holdings make up 35% of its $5.06B portfolio in Q4 2020.
  • Deerfield Management opened 52 new positions and closed 24 in Q4 2020.
  • Deerfield Management's portfolio value rose 23% quarter-over-quarter to $5.06B.

Based on Deerfield Management's 13F filing for Q4 2020, filed 16 Feb 2021.